ATE310247T1 - Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke - Google Patents
Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenkeInfo
- Publication number
- ATE310247T1 ATE310247T1 AT95909102T AT95909102T ATE310247T1 AT E310247 T1 ATE310247 T1 AT E310247T1 AT 95909102 T AT95909102 T AT 95909102T AT 95909102 T AT95909102 T AT 95909102T AT E310247 T1 ATE310247 T1 AT E310247T1
- Authority
- AT
- Austria
- Prior art keywords
- joint
- normal
- information
- aggrecan
- normal aggrecan
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 102000016284 Aggrecans Human genes 0.000 abstract 8
- 108010067219 Aggrecans Proteins 0.000 abstract 8
- 102000016611 Proteoglycans Human genes 0.000 abstract 4
- 108010067787 Proteoglycans Proteins 0.000 abstract 4
- 238000003556 assay Methods 0.000 abstract 3
- 230000001575 pathological effect Effects 0.000 abstract 3
- 208000012659 Joint disease Diseases 0.000 abstract 2
- 238000011156 evaluation Methods 0.000 abstract 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 abstract 2
- 229940099552 hyaluronan Drugs 0.000 abstract 2
- 229920002674 hyaluronan Polymers 0.000 abstract 2
- 238000005259 measurement Methods 0.000 abstract 2
- 210000001179 synovial fluid Anatomy 0.000 abstract 2
- 201000005569 Gout Diseases 0.000 abstract 1
- 206010048873 Traumatic arthritis Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000035474 group of disease Diseases 0.000 abstract 1
- 230000000399 orthopedic effect Effects 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4722—Proteoglycans, e.g. aggreccan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Inspection Of Paper Currency And Valuable Securities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5973994 | 1994-02-19 | ||
| PCT/JP1995/000220 WO1995022765A1 (en) | 1994-02-19 | 1995-02-17 | Method of assaying normal aglycan, assaying kit, and method of judging joint-related information |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE310247T1 true ATE310247T1 (de) | 2005-12-15 |
Family
ID=13121899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95909102T ATE310247T1 (de) | 1994-02-19 | 1995-02-17 | Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5948692A (de) |
| EP (1) | EP0745850B1 (de) |
| JP (1) | JP3694894B2 (de) |
| AT (1) | ATE310247T1 (de) |
| AU (1) | AU705059B2 (de) |
| DE (1) | DE69534619T2 (de) |
| WO (1) | WO1995022765A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5813435A (en) * | 1995-02-06 | 1998-09-29 | Masco Corporation | Single handle mixing valve with an improved ball valve |
| RU2141662C1 (ru) * | 1996-07-08 | 1999-11-20 | Иркутский государственный медицинский университет Минздравмедпрома РФ | Способ прогнозирования развития синовита |
| ATE259505T1 (de) * | 1996-08-15 | 2004-02-15 | Novartis Pharma Gmbh | Test zur quantifizierung von arthritiszustanden |
| US5869273A (en) * | 1996-09-13 | 1999-02-09 | Glyko, Inc. | Chondroitin sulfate as a marker of bone resorption |
| US7067144B2 (en) * | 1998-10-20 | 2006-06-27 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
| US7005274B1 (en) | 1999-09-15 | 2006-02-28 | Migenix Corp. | Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass |
| US6705930B2 (en) * | 2000-01-28 | 2004-03-16 | Lam Research Corporation | System and method for polishing and planarizing semiconductor wafers using reduced surface area polishing pads and variable partial pad-wafer overlapping techniques |
| US7467892B2 (en) * | 2000-08-29 | 2008-12-23 | Imaging Therapeutics, Inc. | Calibration devices and methods of use thereof |
| CN1498385A (zh) * | 2000-08-29 | 2004-05-19 | X图像量析的方法与装置 | |
| US6904123B2 (en) * | 2000-08-29 | 2005-06-07 | Imaging Therapeutics, Inc. | Methods and devices for quantitative analysis of x-ray images |
| US8639009B2 (en) | 2000-10-11 | 2014-01-28 | Imatx, Inc. | Methods and devices for evaluating and treating a bone condition based on x-ray image analysis |
| US7660453B2 (en) | 2000-10-11 | 2010-02-09 | Imaging Therapeutics, Inc. | Methods and devices for analysis of x-ray images |
| ATE440536T1 (de) | 2001-05-25 | 2009-09-15 | Imaging Therapeutics Inc | Verfahren zur diagnose, behandlung und prävention von knochenverlust |
| US7799326B2 (en) * | 2001-09-24 | 2010-09-21 | Mount Sinai School Of Medicine | Methods and compositions for cathespin k complex-mediated disorders |
| US7840247B2 (en) | 2002-09-16 | 2010-11-23 | Imatx, Inc. | Methods of predicting musculoskeletal disease |
| US8965075B2 (en) | 2002-09-16 | 2015-02-24 | Imatx, Inc. | System and method for predicting future fractures |
| JP2007524438A (ja) | 2003-03-25 | 2007-08-30 | イメージング セラピューティクス，インコーポレーテッド | 放射線画像処理技術における補償の方法 |
| US8290564B2 (en) * | 2003-09-19 | 2012-10-16 | Imatx, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| WO2005027732A2 (en) * | 2003-09-19 | 2005-03-31 | Imaging Therapeutics, Inc. | Method for bone structure prognosis and simulated bone remodeling |
| WO2006034018A2 (en) | 2004-09-16 | 2006-03-30 | Imaging Therapeutics, Inc. | System and method of predicting future fractures |
| US7273756B2 (en) * | 2004-10-01 | 2007-09-25 | Isto Technologies, Inc. | Method for chondrocyte expansion with phenotype retention |
| WO2007035397A1 (en) * | 2005-09-15 | 2007-03-29 | The Regents Of The University Of Michigan | Method and system for measuring cartilage condition biomarkers |
| JP2009512844A (ja) * | 2005-10-20 | 2009-03-26 | ノルディック・バイオサイエンス・ダイアグノスティクス・アクティーゼルスカブ | アグリカンおよびそのフラグメントの検出または定量 |
| PL2021792T3 (pl) * | 2006-05-09 | 2013-08-30 | Univ British Columbia | Rozpuszczone białkowe markery zapalenia stawów |
| US8939917B2 (en) | 2009-02-13 | 2015-01-27 | Imatx, Inc. | Methods and devices for quantitative analysis of bone and cartilage |
| AU2012367247B2 (en) | 2012-01-24 | 2018-04-05 | Cd Diagnostics, Inc. | System for detecting infection in synovial fluid |
| JP2018151206A (ja) * | 2017-03-10 | 2018-09-27 | 一丸ファルコス株式会社 | プロテオグリカン分析方法 |
| EP3623816A1 (de) * | 2018-09-12 | 2020-03-18 | GLX Analytix ApS | Glx-abgeleitete moleküldetektion |
| JP2020165937A (ja) * | 2019-03-29 | 2020-10-08 | 国立大学法人弘前大学 | プロテオグリカンの測定方法、評価方法および測定用キット |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH642458A5 (en) * | 1980-04-25 | 1984-04-13 | Hoffmann La Roche | Immunological method |
| CA1160566A (en) * | 1980-04-25 | 1984-01-17 | Harald Gallati | Immunological determination method |
| SE8304836D0 (sv) * | 1983-09-09 | 1983-09-09 | Pharmacia Ab | Sett att bestemma forendringar i ledbrosk |
| US5185245A (en) * | 1989-02-24 | 1993-02-09 | Thomas Jefferson University | Immumoassays and kit for detection of proteoglycans |
| US5032281A (en) * | 1989-08-09 | 1991-07-16 | Daicel Chemical Industries, Ltd. | Separating membrane and separation method |
-
1995
- 1995-02-17 JP JP52171495A patent/JP3694894B2/ja not_active Expired - Fee Related
- 1995-02-17 AU AU17177/95A patent/AU705059B2/en not_active Ceased
- 1995-02-17 AT AT95909102T patent/ATE310247T1/de not_active IP Right Cessation
- 1995-02-17 WO PCT/JP1995/000220 patent/WO1995022765A1/ja not_active Ceased
- 1995-02-17 US US08/687,406 patent/US5948692A/en not_active Expired - Lifetime
- 1995-02-17 EP EP95909102A patent/EP0745850B1/de not_active Expired - Lifetime
- 1995-02-17 DE DE69534619T patent/DE69534619T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3694894B2 (ja) | 2005-09-14 |
| EP0745850B1 (de) | 2005-11-16 |
| DE69534619T2 (de) | 2006-07-13 |
| WO1995022765A1 (en) | 1995-08-24 |
| AU705059B2 (en) | 1999-05-13 |
| US5948692A (en) | 1999-09-07 |
| DE69534619D1 (de) | 2005-12-22 |
| EP0745850A1 (de) | 1996-12-04 |
| EP0745850A4 (de) | 2003-05-28 |
| AU1717795A (en) | 1995-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE310247T1 (de) | Verfahren zur bestimmung von normalem aglycan, bestimmungssatz und verfahren zur beurteilung von informationen bezüglich der gelenke | |
| AU690972B2 (en) | Determination of an individual's inflammation index from whole blood fibrinogen and hematocrit or hemoglobin measurements | |
| Hammad et al. | Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet’s disease: which and when to use? | |
| Fex et al. | Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet. | |
| EP0805215A3 (de) | Diagnostische Methoden und Proben | |
| DE69928809D1 (de) | Differentielle diagnose von neurodegeneration | |
| CY1111229T1 (el) | Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6 | |
| DK1513878T3 (da) | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 | |
| ATE401342T1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| ES2101802T3 (es) | Ensayo para determinar los niveles de igf-i, igf-ii y gh libres en liquidos corporales. | |
| DE69941627D1 (de) | Für krebs | |
| US5185245A (en) | Immumoassays and kit for detection of proteoglycans | |
| DE502005005132D1 (de) | Verfahren zur erhöhung des dynamischen messbereichs von auf spezifischen bindereaktionen basierenden, insbesondere immunologischen testelementen | |
| KR960705211A (ko) | 체액내 bpi의 정량 방법(method for quantifying bpi in body fluids) | |
| Pugia et al. | Clinical utility of a rapid test for uristatin | |
| DE69736336D1 (de) | Verfahren zur messung von blutersatzstoffen | |
| Farrell et al. | Low-cost optical transmittance measurements for the detection and quantification of agglutination in dual-phase lab-in-tubing microfluidics | |
| Gounden et al. | Urine specific gravity measurements: comparison of a new reagent strip method with existing methodologies, as applied to the water concentration/dilution tests | |
| DE69414871D1 (de) | Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten | |
| Grützmeier et al. | Four immunochemical methods for measuring C-reactive protein in plasma compared. | |
| ATE131933T1 (de) | Verfahren zur abtrennung und messung von spurbestandteilen | |
| Bowles et al. | Changes in serum bone-specific alkaline phosphatase following tibial fracture | |
| ATE242487T1 (de) | Verfahren zur bestimmung von schilddrüsen- autoantikörpern | |
| ATE186600T1 (de) | Phosphattest | |
| Erickson et al. | Performance Evaluation of an ELISA for the Quantitative Measurement of α1-Antitrypsin in Stool |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |